Table 1.
Clinical features
| Characteristics | PH (n = 61) | PH+TACE (n = 74) | p value |
|---|---|---|---|
| Age (years) (≤ 53/> 53) | 26/35 | 41/33 | 0.461 |
| Sex (male/female) | 57/4 | 67/7 | 0.540 |
| HBsAg (positive/negative) | 58/3 | 68/6 | 0.460 |
| Cirrhosis (positive/negative) | 49/12 | 61/13 | 0.754 |
| Child-Pugh classification (A/B) | 56/5 | 70/4 | 0.518 |
| AFP (ng/ml) (≤ 400/> 400) | 37/24 | 47/27 | 0.733 |
| GGT (≤ 50 U/L vs > 50 U/L) | 10/51 | 19/55 | 0.191 |
| ALT (U/L) (≤ 75 vs >75) | 47/14 | 62/12 | 0.323 |
| Tumor capsule (positive vs negative) | 35/26 | 38/36 | 0.484 |
| Tumor differentiation (I/II vs III/IV) | 42/19 | 53/21 | 0.726 |
| Total tumor diameter (cm) (mean ± sd) | 5.54 ± 3.13 | 5.68 ± 2.83 | 0.127 |
| tumor biggest diameter (cm) (mean ± sd) | 8.26 ± 3.45 | 8.43 ± 3.46 | 0.773 |
| Number of tumor (2/≥ 3) | 38/23 | 45/29 | 0.860 |